glp-1 cognitive benefits Role of glucagon-like peptide-1 receptor agonists in Alzheimer's disease and Parkinson's disease | Journal of Biomedical Science 8 Benefits of GLP‑1's Beyond

Description

For patients with type 2 diabetes and Hashimoto's, options include: Semaglutide (Ozempic) : Once-weekly injection with robust efficacy for glycemic control, weight loss, and cardiovascular risk reduction Semaglutide (Rybelsus) : Oral daily tablet requiring careful timing with levothyroxine Dulaglutide (Trulicity) : Once-weekly injection with established cardiovascular benefits Liraglutide (Victoza) : Daily injection with cardiovascular risk reduction and extensive long-term safety data Tirzepatide (Mounjaro) : Once-weekly injection combining GLP-1 and GIP receptor agonism, showing superior efficacy in clinical trials For patients with obesity and Hashimoto's, FDA-approved options include: Semaglutide (Wegovy) : Once-weekly injection at higher doses than Ozempic Liraglutide (Saxenda) : Daily injection Tirzepatide (Zepbound) : Once-weekly injection with significant weight loss efficacy The presence of Hashimoto's thyroiditis does not inherently favor one GLP-1 medication over another

Tirzepatide, a dual GIP and GLP-1 receptor agonist, extended this concept by demonstrating even greater weight reduction in adults with obesity or overweight

, Pyke, C

Personalized Prescription Weight Loss Programs Achieving weight loss with willpower alone can be tough

Many patients taking GLP-1 medications like semaglutide (Ozempic, Wegovy) or tirzepatide (Mounjaro, Zepbound) experience digestive side effects including nausea, bloating, and altered bowel habits